Cleared Traditional

K232937 - BTL-899M

K232937 is the FDA 510(k) clearance for BTL-899M by BTL Industries, Inc.. It is a Class 2 Physical Medicine device (product code IPF) cleared through the Traditional 510(k) pathway after a 97-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
97d
Days
Class 2
Risk

K232937 is an FDA 510(k) clearance for the BTL-899M. Classified as Stimulator, Muscle, Powered (product code IPF), Class II - Special Controls.

Submitted by BTL Industries, Inc. (Marlborough, US). The FDA issued a Cleared decision on December 26, 2023 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5850 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all BTL Industries, Inc. devices

Submission Details

510(k) Number K232937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 2023
Decision Date December 26, 2023
Days to Decision 97 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d faster than avg
Panel avg: 115d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IPF Stimulator, Muscle, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - IPF Stimulator, Muscle, Powered

All 134
Devices cleared under the same product code (IPF) and FDA review panel - the closest regulatory comparables to K232937.
Stimulation System (PA series, PR series, S series and Q series)
K232786 · Edan Instruments, Inc. · May 2024
accufit
K233926 · Mettler Electronics Corporation · Mar 2024
M-Wave
K233485 · Zynex Medical, Inc. · Jan 2024
Stim2Go
K230701 · PAJUNK GmbH Medizintechnologie · Nov 2023
Combo Electrotherapy Device
K231440 · Shenzhen Roundwhale Technology Co. , Ltd. · Nov 2023
NeuroTrigger Basic (NTB)
K223027 · Neurotrigger · Oct 2023